Sherlock, TD,  today announced an increased R&D investment by Stryker Instruments at its facility in Carraigtwohill, Co Cork, which will see the Irish facility playing a leading role in the development of new surgical technologies for bone and soft tissue cutting and repair.

The $30M investment by Stryker will see the Cork plant developing the next generation of surgical devices for global markets. The Cork R&D facility will partner with its headquarters in Kalamazoo, Michigan and several other Stryker businesses to develop technologies that will be used in a range of medical procedures as hospitals globally seek new and innovative solutions to medical care challenges.

Read full press release here